JP2018527932A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018527932A5 JP2018527932A5 JP2018511706A JP2018511706A JP2018527932A5 JP 2018527932 A5 JP2018527932 A5 JP 2018527932A5 JP 2018511706 A JP2018511706 A JP 2018511706A JP 2018511706 A JP2018511706 A JP 2018511706A JP 2018527932 A5 JP2018527932 A5 JP 2018527932A5
- Authority
- JP
- Japan
- Prior art keywords
- treg cells
- human
- ifnγ
- cd45rc low
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021133065A JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15306366.4 | 2015-09-07 | ||
| EP15306366 | 2015-09-07 | ||
| PCT/EP2016/070991 WO2017042170A1 (en) | 2015-09-07 | 2016-09-06 | A new subpopulation of cd8+cd45rclow tregs and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021133065A Division JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018527932A JP2018527932A (ja) | 2018-09-27 |
| JP2018527932A5 true JP2018527932A5 (https=) | 2019-09-26 |
Family
ID=54196910
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018511706A Pending JP2018527932A (ja) | 2015-09-07 | 2016-09-06 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
| JP2021133065A Active JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021133065A Active JP7254128B2 (ja) | 2015-09-07 | 2021-08-18 | ＣＤ８＋ＣＤ４５ＲＣｌｏｗ Ｔｒｅｇの新しい亜集団およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20180251731A1 (https=) |
| EP (1) | EP3347452B1 (https=) |
| JP (2) | JP2018527932A (https=) |
| KR (1) | KR102768442B1 (https=) |
| CN (1) | CN108291203A (https=) |
| AU (1) | AU2016318762B2 (https=) |
| BR (1) | BR112018004454A2 (https=) |
| CA (1) | CA2997646C (https=) |
| ES (1) | ES2890818T3 (https=) |
| IL (1) | IL257891B (https=) |
| MX (1) | MX390494B (https=) |
| WO (1) | WO2017042170A1 (https=) |
| ZA (1) | ZA201801265B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3042179A1 (en) * | 2016-10-31 | 2018-05-03 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogenous foxp3 gene |
| EP4417210A1 (en) | 2017-03-15 | 2024-08-21 | Orca Biosystems, Inc. | Compositions and methods for hematopoietic stem cell transplants |
| EP3652306A1 (en) | 2017-07-13 | 2020-05-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for increasing expansion and immunosuppressive capacity of a population of cd8+cd45rclow/-tregs |
| WO2019141774A1 (en) * | 2018-01-19 | 2019-07-25 | Miltenyi Biotec Gmbh | Regulatory t cell expressing a chimeric antigen receptor |
| EP3749334B1 (en) | 2018-02-08 | 2024-12-11 | The Board of Trustees of the Leland Stanford Junior University | Allogenic hematopoietic stem cell transplantation |
| CN111936180B (zh) * | 2018-03-14 | 2024-04-05 | 热动力医疗公司 | 浮力激活细胞分选(bacs)兼容的激活/转导系统和方法 |
| AU2019378883A1 (en) | 2018-11-14 | 2021-06-03 | Flagship Pioneering Innovations V, Inc. | Fusosome compositions for T cell delivery |
| EP3894543A1 (en) * | 2018-12-14 | 2021-10-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8cd45rc low tregs |
| MX2021013227A (es) * | 2019-04-30 | 2022-01-06 | Univ California | Expansion ex-vivo sin microesferas de celulas t reguladoras humanas. |
| AU2020327949A1 (en) * | 2019-08-14 | 2022-03-03 | The Regents Of The University Of California | CAR-T cells specific for modified proteins in extracellular spaces |
| WO2024028486A1 (en) * | 2022-08-04 | 2024-02-08 | Nantes Universite | In vitro method for obtaining clinical-grade cd8+ cd45rclow/- regulatory t cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001253400B2 (en) * | 2000-04-11 | 2007-03-01 | University Of Southern California | A method to prevent graft rejection using tgf-beta to induce t suppressor cells |
| EP2126054B1 (en) * | 2007-01-31 | 2016-07-06 | Yeda Research And Development Company Limited | Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease |
| ES2702676T3 (es) * | 2014-04-01 | 2019-03-04 | Inst Nat Sante Rech Med | Péptido de donante aislado derivado de MHC y usos del mismo |
| US10155025B2 (en) * | 2014-07-17 | 2018-12-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for inhibiting or reducing transplant rejection by adminstration of interleukin-34 |
-
2016
- 2016-09-06 JP JP2018511706A patent/JP2018527932A/ja active Pending
- 2016-09-06 AU AU2016318762A patent/AU2016318762B2/en active Active
- 2016-09-06 CN CN201680064881.0A patent/CN108291203A/zh active Pending
- 2016-09-06 US US15/758,139 patent/US20180251731A1/en not_active Abandoned
- 2016-09-06 CA CA2997646A patent/CA2997646C/en active Active
- 2016-09-06 KR KR1020187009677A patent/KR102768442B1/ko active Active
- 2016-09-06 WO PCT/EP2016/070991 patent/WO2017042170A1/en not_active Ceased
- 2016-09-06 MX MX2018002849A patent/MX390494B/es unknown
- 2016-09-06 ES ES16769882T patent/ES2890818T3/es active Active
- 2016-09-06 EP EP16769882.8A patent/EP3347452B1/en active Active
- 2016-09-06 BR BR112018004454A patent/BR112018004454A2/pt not_active Application Discontinuation
-
2018
- 2018-02-23 ZA ZA2018/01265A patent/ZA201801265B/en unknown
- 2018-03-05 IL IL257891A patent/IL257891B/en active IP Right Grant
-
2021
- 2021-08-18 JP JP2021133065A patent/JP7254128B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018527932A5 (https=) | ||
| Sullivan et al. | Treg-cell-derived IL-35-coated extracellular vesicles promote infectious tolerance | |
| Roncarolo et al. | Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans | |
| Kelsen et al. | FoxP3+ CD4+ CD25+ T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease | |
| Ishikawa et al. | Tregs are dysfunctional in vivo in a spontaneous murine model of Crohn's disease | |
| Castillo et al. | A new method for reactivating and expanding T cells specific for Rhizopus oryzae | |
| Roberts et al. | TNF blockade maintains an IL-10+ phenotype in human effector CD4+ and CD8+ T cells | |
| Sharma et al. | Reduced memory CD4+ T-cell generation in the circulation of young children may contribute to the otitis-prone condition | |
| Davies et al. | Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release | |
| Tawara et al. | Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease | |
| JP5937003B2 (ja) | 免疫介在性疾患における臨床応用のための、抑制機能の高められた制御性ｔ細胞のエクスビボ増加方法 | |
| Pereira et al. | Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations | |
| Ebner et al. | Pathogen-reactive T helper cell analysis in the pig | |
| Radhakrishnan et al. | BCG vaccination reduces the mortality of Mycobacterium tuberculosis–infected type 2 diabetes mellitus mice | |
| Volchenkov et al. | In vitro suppression of immune responses using monocyte-derived tolerogenic dendritic cells from patients with primary Sjögren's syndrome | |
| Zhu et al. | Granzyme B producing B-cells in renal transplant patients | |
| Domingues et al. | Activation of myeloid dendritic cells, effector cells and regulatory T cells in lichen planus | |
| CN107206258A (zh) | 衣原体激活的b细胞平台及其方法 | |
| Teshima et al. | Regulatory T cells and IL-17-producing cells in graft-versus-host disease | |
| Mangus et al. | Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivity | |
| Lin et al. | Expansion of regulatory T cells from umbilical cord blood and adult peripheral blood CD4+ CD25+ T cells | |
| Jin et al. | Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells | |
| Kidzeru et al. | Myeloid-derived suppressor cells and their association with vaccine immunogenicity in South African infants | |
| Kim et al. | Pathological and therapeutic roles of innate lymphoid cells in diverse diseases | |
| Calkoen et al. | Mesenchymal stromal cell therapy is associated with increased adenovirus-associated but not cytomegalovirus-associated mortality in children with severe acute graft-versus-host disease |